File:Sanofi-2022.svg · Wikimedia Commons · See Wikimedia Commons
Sanofi
Also known as Sanofi-Aventis
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89. thumb
Key facts
- Company.name
- Sanofi S.A.
- Company.logo
- Sanofi-2022.svg
- Company.type
- Public
- Company.products
- Medications, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
- Company.revenue_year
- 2024
- Company.operating_income
- €7.252 billion
- Company.income_year
- 2024
- Company.net_income
- €5.618 billion
- Company.net_income_year
- 2024
- Company.assets
- €132.8 billion
- Company.assets_year
- 2024
- Company.equity
- €77.86 billion
Gallery (15)
Connections
Categories
1980s initial public offeringsBiotechnology companies of FranceCAC 40Companies formerly listed on the New York Stock ExchangeCompanies in the Dow Jones Global Titans 50Companies in the Euro Stoxx 50Companies listed on Euronext ParisCompanies listed on the NasdaqFrench brandsFrench companies established in 1973Health care companies established in 1973
